Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device (LVAD) and Medical Management
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate and compare the effectiveness of the HeartMate II
(HM II) Left Ventricular Assist Device (LVAD) support versus OMM in ambulatory NYHA Class
IIIB/IV heart failure patients who are not dependent on intravenous inotropic support and who
meet the FDA approved indications for HM II LVAD destination therapy.